Related Experiment Video
Updated: May 11, 2026
13:07
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Quantifying options for reducing coronary heart disease mortality by 2020.
Mark D Huffman1, Donald M Lloyd-Jones, Hongyan Ning
1Northwestern University Feinberg School of Medicine, Department of Preventive Medicine, 680 N Lake Shore Drive, Suite 1400, Chicago, IL 60611, USA. m-huffman@northwestern.edu
Circulation
|May 11, 2013
Summary
Improving cardiovascular health could prevent 24-30% of coronary heart disease (CHD) deaths by 2020. Focusing on metrics like cholesterol and blood pressure is key, but rising obesity and diabetes pose risks.
Area of Science:
- Public Health
- Epidemiology
- Cardiovascular Disease Research
Background:
- The American Heart Association (AHA) set a 2020 goal for a 20% improvement in US cardiovascular health.
- This study aimed to estimate the potential reduction in coronary heart disease (CHD) deaths to meet this goal.
Purpose of the Study:
- To estimate the potential reduction in coronary heart disease (CHD) deaths by 2020.
- To model the impact of improved cardiovascular health metrics on CHD mortality.
Main Methods:
- Utilized National Health and Nutrition Examination Survey (NHANES) data (1988-2010) for 40,373 adults.
- Quantified trends in 6 cardiovascular health metrics: cholesterol, blood pressure, physical inactivity, smoking, diabetes, and obesity.
- Employed the IMPACT CHD model to project CHD deaths under different scenarios to 2020.
Main Results:
- Without intervention, CHD deaths were projected to increase by 12% to approximately 480,000 in 2020.
- A 20% improvement in all 6 metrics could decrease CHD deaths by 24% to 365,000.
- Continuing recent trends, including increases in diabetes and obesity, could lead to a 30% decrease in CHD deaths (335,000), with improvements in other metrics offset by adverse trends.
Conclusions:
- Achieving a 20% improvement in cardiovascular health metrics could prevent 24% of projected 2020 CHD deaths.
- Continuing negative trends in obesity and diabetes mellitus significantly counteract potential mortality reductions.
- Modeling is a valuable tool for informing public health policy and interventions for cardiovascular disease prevention.
Related Concept Videos
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Coronary Artery Disease I: Introduction
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
01:17Ischemic Heart Disease: Overview
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...